Search clinical trials for: Neutral protamine hagedorn insulin

Total 325 results

Sanofi

Completed

Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM) (B to B)

Diabetes Mellitus, Type 2

Korea, Republic of
Novo Nordisk A/S

Withdrawn

A Research Study, Looking at How NovoMix® Works in People With Type 2 Diabetes in Local Clinical Practice in Algeria (B Simple)

Diabetes Mellitus, Type 2

Algeria
Sanofi

Completed

Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy (SWITCH)

Type 2 Diabetes Mellitus

China
Abertawe Bro Morgannwg University NHS Trust
Novo Nordisk A/S

Unknown

Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA) (LIT)

Latent Autoimmune Diabetes in Adults LADA

United Kingdom
Sanofi

Terminated

Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting (BASAAL PLUS)

Diabetes Mellitus, Type 2

Netherlands
Novo Nordisk A/S

Completed

Comparison of Two Formulations of Biphasic Insulin Aspart 70

Healthy | Diabetes

United Kingdom
Sun Yat-sen University
Eli Lilly and Company; Ministry of Health, China; Amylin Pharmaceuticals, LLC.

Completed

Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

Diabetes Mellitus, Type 2 | Newly Diagnosed

China
Rijnstate Hospital

Completed

LANN-study: Lantus, Amaryl, Novorapid, Novomix Study

Diabetes Mellitus Type II

Netherlands
Novo Nordisk A/S

Completed

Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes (4T)

Diabetes Mellitus, Type 2 | Diabetes

United Kingdom, Ireland
Tehran University of Medical Sciences

Completed

Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients

Diabetes Type 2

Iran, Islamic Republic of
Novo Nordisk A/S

Completed

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects

Healthy | Diabetes

Japan
Sanofi

Terminated

Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction (INTENSIVE)

AMI

Canada, Brazil, United States, Argentina, Mexico
Mackay Memorial Hospital

Completed

Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients (COMPAR)

Diabetes

Taiwan
Imperial College London

Terminated

Management of Type 2 Diabetes After Gastric Bypass Surgery

Diabetes Mellitus, Type 2

United Kingdom
The Medicines Company

Completed

Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB (OPCAB)

Cardiac Surgery | Coronary Artery Bypass Surgery

United States
Wockhardt

Completed

Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects

Diabetes Mellitus

United States
AstraZeneca
Eli Lilly and Company

Completed

Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin

Diabetes Mellitus, Type 2

Taiwan, United Kingdom, Portugal, Spain, Netherlands, Croatia, Slovenia, Greece, Italy, Germany, Romania, Russian Federation
Medical University of South Carolina

Completed

IV Insulin Protocol in Diabetes and Renal Transplantation

Hyperglycemia | Diabetes | Kidney Transplantation

United States
Joslin Diabetes Center
Novo Nordisk A/S

Terminated

Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy

Type 1 Diabetes Mellitus

United States
Charles Drew University of Medicine and Science
National Center for Research Resources (NCRR)

Completed

Insulin Glargine at Bedtime or in AM Versus NPH

Type 2 Diabetes Mellitus

United States
Emory University

Withdrawn

Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient Surgery

Type 1 Diabetes | Type 2 Diabetes

United States
Medical University of Vienna
Medical University of Graz; Charite University, Berlin, Germany; Hospital del...

Completed

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients (ITP-NODAT)

Hyperglycemia
University Hospital, Strasbourg, France

Unknown

Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients (HEPOIRINE)

Cardiac Surgery | Cardiopulmonary Bypass | Obese Patients (BMI ≥ 30 kg/m²)

France
Ohio State University

Recruiting

Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)

Pregnancy, High Risk | Gestational Diabetes Mellitus | Pregnancy in Diabetic

United States
Chinese PLA General Hospital

Completed

Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy

Insulin Pump Therapy in Treating Diabetic Nephropathy
The George Institute
National Health and Medical Research Council, Australia; University of British... and other collaborators

Completed

Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE - SUGAR STUDY)

Hyperglycemia | Critical Illness

Australia
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens (CORRECT)

Diabetic Retinopathy

China
Population Health Research Institute

Completed

REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study) (RECREATE Pilot)

Hyperglycemia | Myocardial Infarction | Cardiovascular Diseases

Argentina, Canada, India
University of Colorado, Denver

Completed

Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software

Diabetes

United States
University Hospital, Basel, Switzerland

Completed

Modulating the Stress Response in Diabetes Mellitus Type 2 Patients Undergoing Colon Surgery

Insulin Resistance | Diabetes Mellitus Type 2
University of Roma La Sapienza

Unknown

Intensive Insulin Therapy for Strict Glycemic Control in Neurosurgical Patients: Safety and Efficacy

Traumatic Brain Injury | Subarachnoid Hemorrhage | Intracranial Hemorrhage

Italy
Eli Lilly and Company

Recruiting

A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

Healthy | Type 1 Diabetes Mellitus

Germany
Huazhong University of Science and Technology

Recruiting

Hybrid Closed-loop Insulin Delivery System in Perioperative Diabetic Patients: an Open-label, Randomized Controlled Trial

Diabetes Mellitus

China
Emory University

Completed

Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery (SITA-CABGDM)

Hyperglycemia

United States
Centre for Addiction and Mental Health

Recruiting

Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia

Healthy | Schizophrenia

Canada
American Heart Association
Eli Lilly and Company

Completed

Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients

Glycemic Control

United States
University of Louisville

Terminated

Normoglycemia and Neurological Outcome

Brain Injuries | Acute, Non-traumatic Subarachnoid Hemorrhage | Intraparenchymal Hemorrhage

United States
Fundación para la Investigación del Hospital Clínico...
Universitat Politècnica de València

Completed

Effect of Different Plasma Insulin Levels on the Accuracy of Continuous Subcutaneous Glucose Monitoring

Hypoglycemia | Type 1 Diabetes | Continuous Glucose Monitoring

Spain
Merck Sharp & Dohme LLC

Completed

A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)

Type 1 Diabetes Mellitus
Sanofi

Completed

Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

United States, Chile, Czech Republic, Denmark, France, Germany, Hungary, Lithuania, Mexico, Poland, Romania, Slovakia, Sweden
Emory University

Completed

Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery (SITACABG NonDM)

Coronary Artery Disease

United States
Manchester University NHS Foundation Trust
Novo Nordisk A/S

Completed

Comparison of Day and Night Closed-loop With Faster-acting Insulin Aspart With Insulin Aspart (AP-MFT-01)

Diabetes Mellitus, Type 1

United Kingdom
Kinderkrankenhaus auf der Bult
Hannover Medical School

Withdrawn

How to be Safe With Alcoholic Drinks in Diabetes (BEER)

Hypoglycemia | Type 1 Diabetes Mellitus

Germany
Boston Children's Hospital
Beth Israel Deaconess Medical Center; Brigham and Women's Hospital

Completed

Dietary Glycemic Index, Brain Function and Food Intake in Patients With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

United States
Northwestern University

Withdrawn

Supraphysiologic Insulin to Improve Outcomes After Surgical Treatment of Unruptured Cerebral Aneurysms

Intracranial Aneurysm

United States
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-L)

Type 2 Diabetes

United States, Australia, Canada, Chile, Czech Republic, Denmark, Estonia, Hungary, Lithuania, Mexico, Netherlands, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine
University of Virginia
Medical University of South Carolina; National Institute of Neurological Disorders... and other collaborators

Completed

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial (SHINE)

Hyperglycemia | Diabetes | Acute Ischemic Stroke

United States
Sanofi

Completed

Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM (LixiLan-O)

Type 2 Diabetes

Australia, Denmark, South Africa, Spain, Belgium, Russian Federation, Canada, Estonia, Hungary, Latvia, Mexico, United States, Chile, Czech Republic, France, Germany, Italy, Lithuania, Poland, Romania, Sweden, Ukraine, United Kingdom
Yangzhou University

Completed

The Primary Objective of This Study Was to Investigate the Effect of Insulin on Myocardial Perfusion and Cardiac Function in Patients Undergoing Cardiac Surgery for CPB Using Transesophageal Echocardiography (TEE) to Detect CSBF

Insulin

China
Hospices Civils de Lyon

Terminated

Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study. (CONTROLING)

Critical Illness

France

Search clinical trials for: Neutral protamine hagedorn insulin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations